G. Kenneth Lloyd
Chief Tech/Sci/R&D Officer at BEYONDSPRING INC.
Net worth: 145 088 $ as of 2024-03-30
Profile
G.
Kenneth Lloyd is the founder of GKOL, Inc. He is currently the Chief Scientific Officer at BeyondSpring, Inc. Dr. Lloyd received his undergraduate and graduate degrees from McGill University and his doctorate from the University of Toronto.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BEYONDSPRING INC.
0.10% | 2023-02-28 | 40,641 ( 0.10% ) | 145 088 $ | 2024-03-30 |
G. Kenneth Lloyd active positions
| Companies | Position | Start |
|---|---|---|
| BEYONDSPRING INC. | Chief Tech/Sci/R&D Officer | 2015-05-31 |
Former positions of G. Kenneth Lloyd
| Companies | Position | End |
|---|---|---|
| Dalian Wanchun Biotechnology Co. Ltd. | Chief Tech/Sci/R&D Officer | 2013-12-31 |
Nereus Pharmaceuticals, Inc.
 Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 2013-04-28 |
A.E. Wyeth & Co.
 A.E. Wyeth & Co. Miscellaneous Commercial ServicesCommercial Services Part of Vizards Staples & Bannisters, A.E. Wyeth & Co. is a legal services provider. The private company is based in Dartford, UK. A.E. Wyeth was acquired by Vizards Staples & Bannisters on July 11, 2001. | Chief Tech/Sci/R&D Officer | - |
| Sanofi SA | Corporate Officer/Principal | - |
Verne Mendel Medical Corp.
 Verne Mendel Medical Corp. Pharmaceuticals: MajorHealth Technology Verne Mendel Medical Corp. develops pharmaceutical product candidates to treat mitochondrial degenerative diseases. Its products include candidates treat neurodegenerative group diseases, such as Parkinson’s, Alzheimer’s, and Lou Gehrig’s; stroke, glaucoma, deafness, and inherited mitochondrial diseases; and metabolic group diseases, including diabetes, and its cardiac and neurologic complications. The company is headquartered in San Diego, CA. | Director/Board Member | - |
Training of G. Kenneth Lloyd
| McGill University | Graduate Degree |
| University of Toronto | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BEYONDSPRING INC. | Health Technology |
| Private companies | 8 |
|---|---|
| Sibia Neurosciences, Inc. | Health Technology |
A.E. Wyeth & Co.
A.E. Wyeth & Co. Miscellaneous Commercial ServicesCommercial Services Part of Vizards Staples & Bannisters, A.E. Wyeth & Co. is a legal services provider. The private company is based in Dartford, UK. A.E. Wyeth was acquired by Vizards Staples & Bannisters on July 11, 2001. | Commercial Services |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Commercial Services |
| Wyeth-Ayerst Research | |
| Sanofi SA | Health Technology |
| GKOL, Inc. | |
Verne Mendel Medical Corp.
Verne Mendel Medical Corp. Pharmaceuticals: MajorHealth Technology Verne Mendel Medical Corp. develops pharmaceutical product candidates to treat mitochondrial degenerative diseases. Its products include candidates treat neurodegenerative group diseases, such as Parkinson’s, Alzheimer’s, and Lou Gehrig’s; stroke, glaucoma, deafness, and inherited mitochondrial diseases; and metabolic group diseases, including diabetes, and its cardiac and neurologic complications. The company is headquartered in San Diego, CA. | Health Technology |
| Dalian Wanchun Biotechnology Co. Ltd. |
- Stock Market
- Insiders
- G. Kenneth Lloyd
